Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial - Eriksson, B I; Dahl, O E; Rosencher, N (J Thromb Haemost, 2007)
, et al; RE-MODEL Study Group.